CLINICAL TRIAL: TESTOSTERONE DOSE RESPONSE IN SURGICALLY POSTMENOPAUSAL WOMEN

$36,404U54FY2011RRNIH

Charles R. Drew University Of Med & Sci, Los Angeles CA

Investigators

Linked publications, trials & patents

Paper 29304027 Paper 29257942 Paper 28405342 Paper 27599978 Paper 27151588 Paper 26958235 Paper 26251956 Paper 26120244 Paper 25678848 Paper 25011019 Paper 24855160 Paper 24830635 Paper 24804366 Paper 24768273 Paper 24652724 Paper 24551394 Paper 24551351 Paper 24356589 Paper 24328648 Paper 24314367 Paper 24119846 Paper 24050539 Paper 23981394 Paper 23974394 Paper 23922552 Paper 23920536 Paper 23589025 Paper 23530303 Paper 23459206 Paper 23436163 Paper 23395954 Paper 23304294 Paper 23277041 Paper 23258127 Paper 23254254 Paper 23230959 Paper 23045433 Paper 23045431 Paper 23033239 Paper 23027732 Paper 23010760 Paper 22997511 Paper 22982629 Paper 22875280 Paper 22789879 Paper 22708252 Paper 22672418 Paper 22626510 Paper 22495468 Paper 22389092 Paper 22339900 Paper 22339899 Paper 22339898 Paper 22308829 Paper 22289886 Paper 22232147 Paper 22212390 Paper 22212225 Paper 22200433 Paper 22195163 Paper 22195095 Paper 22102304 Paper 22102302 Paper 22052051 Paper 22009636 Paper 22005266 Paper 21813809 Paper 21784835 Paper 21673099 Paper 21659728 Paper 21633409 Paper 21601328 Paper 21570964 Paper 21550951 Paper 21527646 Paper 21424555 Paper 21338849 Paper 21338847 Paper 21293117 Paper 21278812 Paper 21269401 Paper 21239093 Paper 21196721 Paper 21189749 Paper 21175833 Paper 21170574 Paper 21076895 Paper 20979972 Paper 20979953 Paper 20841679 Paper 20820841 Paper 20803415 Paper 20614473 Paper 20592243 Paper 20437741 Paper 20144693 Paper 20121705 Paper 19954950 Paper 19264935

Abstract

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. 1. Primary objective of this study is to establish testosterone dose-response relationships in surgically menopausal women with low testosterone concentrations for a range of androgen-dependent outcomes, including sexual function, fat-free mass, thigh muscle strength and leg power, several domains of neurocognitive function, plasma lipids, apolipoproteins and lipoprotein particles, and insulin sensitivity. 2. The secondary objective is to determine the range of testosterone doses and subsequent plasma testosterone concentrations that are associated with improvements in sexual, physical and neurocognitive functions and that can be safely administered to women without significant adverse effects.

View original record on NIH RePORTER →